No Data
No Data
Earnings Update: Pacific Biosciences of California, Inc. (NASDAQ:PACB) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
PacBio to Present at Upcoming Investor Conferences
Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session
TD Cowen Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Raises Target Price to $4
Pacific Biosciences of California, Inc. (PACB) Q3 2024 Earnings Call Transcript Summary
Pacific Biosciences Of California, Inc. Q3 Loss Decreases, Beats Estimates
No Data
No Data